top of page

Mwandishi:

Mhariri:

Imeboershwa:

ULY CLINIC

ULY CLINIC

17 Februari 2026, 14:31:27

Atopic Eczema
Atopic Eczema

Atopic Eczema

Atopic eczema, also called atopic dermatitis, is a chronic, relapsing inflammatory skin disorder that occurs on a background of atopy.

  • There is often a personal or family history of atopic diseases such as:

    • Asthma

    • Allergic rhinitis (hay fever)

    • Atopic dermatitis

  • The disease is characterized by intense pruritus, xerosis (dry skin), and eczematous lesions that vary with age.

  • Eczema is often triggered or exacerbated by environmental factors, allergens, irritants, infections, or stress.


Clinical Forms and Diagnostic Criteria

Atopic eczema can present differently depending on the patient’s age and disease stage.


Infantile Eczema (“Milk Crust”)

  • Usually appears around 3 months of age

  • Lesions are oozing, crusted, and typically involve:

    • Cheeks

    • Forehead

    • Scalp

Important: If generalized exfoliative dermatitis develops, refer to a higher-level facility for specialist care.


Flexural Eczema

  • Onset around 3–4 years of age

  • Predominantly affects flexural surfaces:

    • Elbows

    • Knees

    • Nape of the neck

  • Features include:

    • Thickening and lichenification

    • Intense pruritus, often worse at night

Note: Eczema may evolve through three stages:

  1. Acute – weeping lesions

  2. Subacute – crusted lesions

  3. Chronic – lichenified, scaly skin


Signs & Symptoms

  • Intense itching (pruritus)

  • Erythema and inflammation

  • Oozing or crusted lesions (in acute phase)

  • Lichenification and hyperpigmentation (in chronic phase)

  • Xerosis (dry, rough skin)

  • Secondary infections (bacterial, viral, or fungal)

  • Excoriations due to scratching


Investigations

Routine investigations are usually not required, but may be considered in complicated or atypical cases:

  • Skin swab for bacterial culture (if secondary infection suspected)

  • Patch testing for contact allergens

  • IgE levels in severe or atypical presentations

  • Skin biopsy (rarely) if diagnosis is uncertain


Treatment

Management of atopic eczema is multimodal, involving non-pharmacological and pharmacological strategies.


Non-Pharmacological Treatment

  • Patient Education: Explain chronic nature, triggers, and importance of adherence

  • Avoid Triggers:

    • Skin irritants (soaps, detergents, wool, harsh cleansers)

    • Extreme temperatures

    • Allergens

  • Emollients:

    • Generous use of skin moisturizers (emulsifying ointments, aqueous creams)

    • Bath oils or soap substitutes

  • Bathing Practices:

    • Short lukewarm baths

    • Avoid prolonged soaking or harsh scrubbing


Pharmacological Treatment


Antihistamines (for pruritus)

  • Promethazine 25 mg PO at bedtime (may increase to 50 mg if needed)

  • Cetirizine 10 mg PO once daily

  • Loratadine 10 mg PO once daily


Topical Corticosteroids

  • Mild lesions / delicate skin surfaces:

    • Hydrocortisone 1% ointment, apply 12-hourly

  • Moderate lesions:

    • Betamethasone valerate 0.025% cream/ointment, apply 12-hourly for 2 weeks


Severe or Refractory Cases

  • Adjunct therapies:

    • Sedating antihistamines

    • Occlusive bandaging

    • Short course systemic corticosteroids (e.g., Prednisolone)

  • Treat secondary infections (bacterial or viral) promptly


Wet (“Weepy”) Lesions

  • Saline or Potassium permanganate 1:4000 (0.025%) baths once daily for 2–4 days until dry

  • If extensive, prescribe antibiotics for 5–10 days (as for impetigo)


Chronic / Lichenified Skin

  • Apply emollients (emulsifying ointment or liquid paraffin)

  • Use the mildest effective topical steroid, applied thinly twice daily

  • Avoid potent steroids on facial or delicate skin


Classes of Topical Steroids

  • Very Potent: 0.05% Clobetasol propionate

  • Potent: 0.1% Betamethasone valerate

  • Diluted Potent: 0.025% Betamethasone valerate

  • Moderately Potent: 0.05% Clobetasol butyrate

  • Mild: 1% Hydrocortisone

Caution: Long-term or extensive use may cause:

  • Striae

  • Acne

  • Hyperpigmentation or hypopigmentation

  • Skin atrophy

  • Hirsutism

Patient education: Avoid use as cosmetic for skin lightening.


Prevention

  • Consistent use of emollients

  • Avoid known irritants and allergens

  • Maintain regular bathing and skin care routines

  • Early treatment of infections

  • Avoid scratching (use gloves for infants at night if needed)


Complications

  • Secondary bacterial infection (Staphylococcus aureus)

  • Viral infections (eczema herpeticum)

  • Lichenification and permanent hyperpigmentation

  • Sleep disturbance due to nocturnal pruritus


Prognosis

  • Chronic and relapsing; severity may reduce with age

  • Proper skin care and trigger avoidance improves quality of life

  • Severe cases may require specialist dermatology car


References

  1. Tanzania Ministry of Health. Standard Treatment Guidelines & National Essential Medicines List (STG/NEMLIT). 7th ed. Dodoma: MoH; 2023.

  2. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol. 2014;71(1):116–132.

  3. Williams HC. Atopic dermatitis. N Engl J Med. 2005;352:2314–2324.

  4. Boguniewicz M, Leung DY. Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242:233–246.

  5. World Health Organization. WHO Model Formulary 2023. Geneva: WHO; 2023.


Imeandikwa;

3 Novemba 2020, 12:19:48

bottom of page